NY Hemp Depot

NY Hemp Depot was a U.S. hemp-focused operating entity formed as a wholly owned subsidiary of Canbiola to support hemp aggregation, processing logistics, and supply-chain integration in New York. Public disclosures described it as part of a joint venture structure intended to purchase harvested industrial hemp from third-party farmers, manage a processing facility, and potentially supply feminized seeds and clones. The business appears to have been tied to hemp/CBD raw-material sourcing and processing infrastructure rather than a traditional drug-development pipeline. There is no evidence that NY Hemp Depot operated as a clinical-stage biotech or pharmaceutical developer with named therapeutic programs. Based on later parent-company disclosures stating its hemp cultivation division was non-operational, NY Hemp Depot appears inactive as an operating healthcare-related business.